Course Exam
301907 VO Development of novel cancer immunotherapies (2020W)
from target identification through target validation to clinical trials
Labels
WHEN?
digitale schriftliche Prüfungen mit offenen Fragen mittels eines Prüfungsbogens zum Download
Registration/Deregistration
Note: The time of your registration within the registration period has no effect on the allocation of places (no first come, first served).
- Registration is open from Th 01.10.2020 09:00 to Su 24.01.2021 12:00
- Deregistration possible until Su 24.01.2021 12:00
Examiners
Information
Assessment and permitted materials
written exam
Minimum requirements and assessment criteria
100-87%: Sehr Gut ( I ); 87,99-75%: Gut (2); 74,99-62%: Befriedigend (3); 6 I ,99-50%: Genügend (4); < 50%: Nicht Genügend (5)
Last modified: Fr 12.05.2023 00:24